CHELVERTON GROWTH TRUST PLC
INTERIM MANAGEMENT STATEMENT
For the period ended 30 November 2011
INVESTMENT OBJECTIVE
The investment objective of the Company is to provide capital growth through
investment in companies listed on the Official List and traded on the
Alternative Investment Market (`AIM') with a market capitalisation at the time
of investment of up to £50 million, which are believed to be at a `point of
change'. Its investment objective is to increase net asset value per share at a
higher rate than other quoted smaller company trusts and the FTSE All-Share
Index.
INVESTMENT POLICY
The Company invests principally in securities of publicly quoted UK companies,
though it may invest in unquoted securities. The concentrated UK portfolio
comprises between 20 to 35 securities. The performance of the Company's
investments is compared to the FTSE All-Share Index. The Company will also
invest in unquoted investments where it is believed that there is a likelihood
of the shares becoming listed or traded on AIM or the investee company being
sold. The Company will not invest in any listed investment companies or listed
investment trusts.
It is intended from time to time, when deemed appropriate, that the Company
will borrow for investment purposes, it currently has no borrowings.
The investment objective and policy stated above are intended to distinguish
the Company from other investment vehicles which have relatively narrow
investment objectives and which are constrained in their decision making and
asset allocation. The objective and policy allow the Company to be constrained
in its investment selection only by valuation and to be pragmatic in portfolio
construction by only investing in securities which the Investment Manager
considers to be undervalued on an absolute basis.
KEY FACTS
Net asset value (NAV) per Ordinary 31.40p
share*
Ordinary share price 24.00p
Discount 23.57%
PERFORMANCE - TOTAL RETURN
For the period ended 30 November 2011
NAV* 2.61%
Share Price 9.09%
FTSE All Share Index 2.11%
FTSE Small-Cap Index (8.12%)
*Based on NAV including current period revenue
MATERIAL DEVELOPMENTSANDTRANSACTIONS
On 21 December 2011 Shareholders passed all resolutions at the Company's Annual
General Meeting and accordingly approved the resolution pertaining to the
proposed Tender Offer and Buyback.
As announced on 28 December 2011 and pursuant to the Tender Offer,
1,323,334Ordinary shares and to the buyback offer, 25,727 Ordinaryshares will
be repurchased for cancellation with settlement on 23 January 2012.
As a result of the above, there will be 11,884,283 Ordinary shares of 1p each
in issue. The above figure may be used from 23 January 2012, by Shareholders as
the denominator for the calculations by which they will determine if they are
required to notify their interest in, or a change to their interest in, the
Company under the FSA's Disclosure and Transparency Rules.
DISTRIBUTION OF ASSETS AND LIABILITIES
30 November 2011 31 August 2011
£'000 £'000
AIM traded investments - Ordinary 3,660 3,576
shares
Delisted and unquoted 457 479
4,117 4,055
Current assets/(liabilities) 38 (6)
Net assets 4,155 4,049
Net asset value per Ordinary share 31.40p 30.60p
Name of company % of portfolio
1 IDOX 33.47
2 AI Claims Solutions 13.27
3 Parmenion Capital Partners LLP 9.66
4 Belgravium Technologies 7.29
5 Alliance Pharma 6.63
6 CEPS 4.85
7 Tristel 3.69
8 PSG Solutions 3.67
9 Pennant International Group 2.94
10 Northbridge Industrial Services 2.71
11 LPA Group 2.60
12 Titan Europe 2.26
13 Sanderson Group 1.89
14 One Horizon Group 1.44
15 Datong Electronics 1.16
16 MTI Wireless Edge 1.10
17 Richoux Group 0.88
18 Petards Group 0.28
19 Universe Group 0.21
Balance held in 3 holdings 0.00
100.00
Note: The Directors are not aware of any significant events or transactions
which have occurred between the date of the financial information and the date
of publication, which would have a material impact on the financial position of
the Company.
The net asset value is published on a monthly basis and other useful background
information on the Company including downloads of published documentation such
as previous Annual Reports and Monthly Fact Sheets can be found at
www.chelvertonam.com .
COMPANY INFORMATION
Launch date: 12 May 1999
Year end: 31 August
Results announced:
Half-year - April
Final - November
AGM - December
Price information is published in the Financial Times under 'Investment
Companies'.
This interim management statement has been produced solely to provide
additional information to shareholders as a body to meet the relevant
requirements of the UK Listing Authority's Disclosure and Transparency rules.
It should not be relied upon by any other party or for any other purposes. In
addition, the views, information and data in this publication should not be
deemed as a financial promotion or recommendation.
Contact:
William van Heesewijk
Chelverton Asset Management Limited
Tel: 0207 222 8989
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.